ELECTROOSMOTIC TISSUE TREATMENT

Abstract

Apparatus for driving fluid between first and second anatomical sites of a subject is provided, comprising (1) a first electrode, configured to be coupled to the first anatomical site of the subject; (2) a second electrode, configured to be coupled to the second anatomical site of the subject; and (3) a control unit, configured to (i) detect a pressure difference between the first and second anatomical sites, and (ii) in response to the detected pressure difference, drive fluid between the first and second anatomical sites by applying a treatment voltage between the first and second electrodes. Other embodiments are also described.

Claims

1. Apparatus for driving fluid between first and second anatomical sites of a subject, the apparatus comprising: a first electrode, configured to be coupled to the first anatomical site of the subject; a second electrode, configured to be coupled to the second anatomical site of the subject; and a control unit, configured to: detect a pressure difference between the first and second anatomical sites, and in response to the detected pressure difference, drive fluid between the first and second anatomical sites by applying a treatment voltage between the first and second electrodes.

2. The apparatus according to claim 1, wherein the control unit is configured to provide a rest period during which the treatment voltage is not applied, and to apply, between the first and second electrodes, an opposite voltage that is opposite to the treatment voltage and that has a lower magnitude than the treatment voltage.

3. The apparatus according to claim 1, wherein each electrode is insulated such that no portion of the electrode may be in electrical contact with any tissue of the subject, and wherein the control unit is configured to drive a capacitative current between the first and second insulated electrodes by applying the treatment voltage between the electrodes.

4. The apparatus according to any one of claims 1-3, further comprising a pressure sensor, wherein the apparatus is configured to detect the pressure difference by the pressure sensor being configured to detect the pressure difference.

5. The apparatus according to claim 4, wherein the pressure sensor comprises a mechanical pressure sensor, configured to detect the pressure difference at least in part by detecting mechanical pressure pressing on a component of the pressure sensor.

6. The apparatus according to claim 5, wherein the pressure sensor comprises at least a first mechanical pressure sensor, configured to detect the pressure at the first anatomical site, and a second mechanical pressure sensor, configured to detect the pressure at the second anatomical site.

7. The apparatus according to any one of claims 1-3, wherein the apparatus is configured to detect the pressure difference by detecting a voltage between the first and second electrodes, and wherein the control unit is configured to apply the treatment in response to the detected pressure difference by being configured to apply the treatment voltage in response to the detected voltage.

8. The apparatus according to claim 7, wherein the apparatus is configured to detect the detected voltage by being configured to detect a streaming voltage.

9. The apparatus according to claim 7, wherein the apparatus is configured not to apply the treatment voltage while detecting the detected voltage.

10. The apparatus according to claim 7, wherein the control unit comprises voltage-detecting circuitry, configured to detect the voltage.

11. The apparatus according to any one of claims 1-3, wherein the first anatomical site includes a superior sagittal sinus of the subject, the second anatomical site includes a cerebral cortex of the subject, and the control unit is configured to electroosmotically drive the fluid by electroosmotically driving the fluid between the superior sagittal sinus and the cerebral cortex of the subject.

12. The apparatus according to claim 11, wherein the control unit is configured to electroosmotically drive the fluid from the cerebral cortex to the superior sagittal sinus of the subject.

13. The apparatus according to claim 11, wherein the control unit is configured to detect the pressure by being configured to detect a voltage between the first and second electrodes.

14. The apparatus according to any one of claims 1-3, wherein the first anatomical site includes a renal artery of the subject, the second anatomical site includes a ureter of the subject, and the control unit is configured to configure the treatment voltage to electroosmotically drive the fluid by electroosmotically driving the fluid between the renal artery and the ureter of the subject.

15. The apparatus according to claim 14, wherein the control unit is configured to electroosmotically drive the fluid from the renal artery to the ureter of the subject.

16. The apparatus according to claim 14, wherein the control unit is configured to detect the pressure by being configured to detect a voltage between the first and second electrodes.

17. The apparatus according to any one of claims 1-3, wherein the first anatomical site includes an artery entering a lymph node of the subject, the second anatomical site includes a medullary sinus of the lymph node of the subject, and the control unit is configured to electroosmotically drive the fluid by electroosmotically driving the fluid between the artery and the medullary sinus of the subject.

18. The apparatus according to claim 17, wherein the control unit is configured to electroosmotically drive the fluid from the artery to the medullary sinus of the subject.

19. The apparatus according to claim 17, wherein the control unit is configured to detect the pressure by being configured to detect a voltage between the first and second electrodes, and to apply the treatment voltage only when the detected voltage is greater than.

20. The apparatus according to any one of claims 1-3, wherein the first anatomical site includes a vitreous cavity of an eye of the subject, the second anatomical site includes a Schlemm's canal of the subject, and the control unit is configured to electroosmotically drive the fluid by electroosmotically driving the fluid between the vitreous cavity and the Schlemm's canal of the subject.

21. The apparatus according to claim 20, wherein the control unit is configured to electroosmotically drive the fluid from the vitreous cavity to the Schlemm's canal of the subject.

22. The apparatus according to claim 20, wherein the control unit is configured to detect the pressure by being configured to detect a voltage between the first and second electrodes.

23. The apparatus according to any one of claims 1-3, wherein the first anatomical site includes a site within a subarachnoid cavity of the subject, the second anatomical site includes a site outside of the subarachnoid cavity of the subject, and the control unit is configured to electroosmotically drive the fluid by electroosmotically driving the fluid between the site within the subarachnoid cavity and the site outside of the subarachnoid cavity of the subject.

24. The apparatus according to claim 23, wherein the control unit is configured to electroosmotically drive the fluid from the site within the subarachnoid cavity to the site outside of the subarachnoid cavity of the subject.

25. The apparatus according to claim 23, wherein the control unit is configured to detect the pressure by being configured to detect a voltage between the first and second electrodes.

26. A method, comprising: detecting a pressure difference between a first anatomical site and a second anatomical site of a subject; and in response to the detected pressure difference, electroosmotically driving fluid between the first and second anatomical sites by applying a treatment voltage between the first and second anatomical sites.

27. The method according to claim 26, further comprising providing a rest period during which the treatment voltage is not applied, and applying, during the rest period, an opposite voltage between the first and second anatomical sites, the opposite voltage being opposite to the treatment voltage and having a lower magnitude than the treatment voltage.

28. The method according to any one of claims 26-27, further comprising implanting a first electrode at the first anatomical site, and implanting a second electrode at the second anatomical site, and wherein applying the treatment voltage between the first and second anatomical sites comprises applying the treatment voltage between the first and second electrodes.

29. The method according to claim 28, wherein: implanting the first electrode comprises implanting a first insulated electrode, such that no portion of the first insulated electrode is in electrical contact with any tissue of the subject, implanting the second electrode comprises implanting a second insulated electrode, such that no portion of the second insulated electrode is in electrical contact with any tissue of the subject, and applying the treatment voltage comprises driving a capacitative current between the first and second insulated electrodes.

30. The method according to any one of claims 26-27, wherein detecting the pressure difference comprises detecting the pressure difference using at least one mechanical pressure sensor.

31. The apparatus according to claim 30, wherein detecting the pressure difference comprises detecting a pressure at the first anatomical site using a first mechanical pressure sensor, and detecting a pressure at the second anatomical site using a second mechanical pressure sensor.

32. The method according to any one of claims 26-27, wherein detecting the pressure difference comprises detecting the pressure difference by detecting a voltage between the first and second electrodes, and wherein applying the treatment voltage in response to the detected pressure difference comprises applying the treatment voltage in response to the detected voltage.

33. The method according to claim 32, wherein detecting the detected voltage comprises detecting a streaming voltage.

34. The method according to claim 32, wherein applying the treatment voltage comprises not applying the treatment voltage while detecting the detected voltage.

35. The method according to any one of claims 26-27, wherein: the first anatomical site includes a superior sagittal sinus of the subject, the second anatomical site includes a cerebral cortex of the subject, and electroosmotically driving the fluid between the first and second anatomical sites comprises electroosmotically driving the fluid between the superior sagittal sinus and the cerebral cortex of the subject.

36. The method according to claim 35, wherein driving the fluid between the superior sagittal sinus and the cerebral cortex of the subject comprises driving the fluid from the cerebral cortex to the superior sagittal sinus of the subject.

37. The method according to claim 35, wherein detecting the pressure difference comprises detecting the pressure difference by detecting a voltage between the first and second electrodes.

38. The method according to any one of claims 26-27, wherein: the first anatomical site includes a renal artery of the subject, the second anatomical site includes a ureter of the subject, and electroosmotically driving the fluid between the first and second anatomical sites comprises electroosmotically driving the fluid between the renal artery and the ureter of the subject.

39. The method according to claim 38, wherein driving the fluid between the renal artery and the ureter of the subject comprises driving the fluid from the renal artery to the ureter of the subject.

40. The method according to claim 38, wherein detecting the pressure difference comprises detecting the pressure difference by detecting a voltage between the first and second electrodes.

41. The method according to any one of claims 26-27, wherein: the first anatomical site includes an artery entering a lymph node of the subject, the second anatomical site includes a medullary sinus of the lymph node of the subject, and electroosmotically driving the fluid between the first and second anatomical sites comprises electroosmotically driving the fluid between the artery entering a lymph node and the medullary sinus of the subject.

42. The method according to claim 41, wherein driving the fluid between the artery entering the lymph node and the medullary sinus of the subject comprises driving the fluid from the medullary sinus to the artery entering the lymph node of the subject.

43. The method according to claim 41, wherein detecting the pressure difference comprises detecting the pressure difference by detecting a voltage between the first and second electrodes.

44. The method according to any one of claims 26-27, wherein: the first anatomical site includes a vitreous cavity of an eye of the subject, the second anatomical site includes a Schlemm's canal of the eye of the subject, and electroosmotically driving the fluid between the first and second anatomical sites comprises electroosmotically driving the fluid between the vitreous cavity and the Schlemm's canal of the subject.

45. The method according to claim 44, wherein driving the fluid between the vitreous cavity and the Schlemm's canal of the subject comprises driving the fluid from the vitreous cavity to the Schlemm's canal of the subject.

46. The method according to claim 44, wherein detecting the pressure difference comprises detecting the pressure difference by detecting a voltage between the first and second electrodes.

47. The method according to any one of claims 26-27, wherein: the first anatomical site includes a nucleus pulposus of an intervertebral disc of the subject, the second anatomical site includes a site outside of the nucleus pulposus of the disc of the subject, and electroosmotically driving the fluid between the first and second anatomical sites comprises electroosmotically driving the fluid between the nucleus pulposus and the site outside of the nucleus pulposus of the subject.

48. The method according to claim 47, wherein driving the fluid between the nucleus pulposus and the site outside of the nucleus pulposus of the subject comprises driving the fluid from the nucleus pulposus to the site outside of the nucleus pulposus of the subject.

49. The method according to claim 47, wherein driving the fluid between the nucleus pulposus and the site outside of the nucleus pulposus of the subject comprises driving the fluid from the site outside of the nucleus pulposus to the nucleus pulposus of the subject.

50. The method according to claim 47, wherein detecting the pressure difference comprises detecting the pressure difference by detecting a voltage between the first and second electrodes.

51. The method according to any one of claims 26-27, wherein: the first anatomical site includes a site within a subarachnoid cavity of the subject, the second anatomical site includes a site outside of the subarachnoid cavity of the subject, and electroosmotically driving the fluid between the first and second anatomical sites comprises electroosmotically driving the fluid between the site within the subarachnoid cavity of the subject and the site outside of the subarachnoid cavity of the subject.

52. The method according to claim 51, wherein driving the fluid between the site within the subarachnoid cavity and the site outside of the subarachnoid cavity of the subject comprises driving the fluid from the site within the subarachnoid cavity to the site outside of the subarachnoid cavity of the subject.

53. The method according to claim 51, wherein detecting the pressure difference comprises detecting the pressure difference by detecting a voltage between the first and second electrodes.

54. A method, comprising: electroosmotically driving fluid between a superior sagittal sinus of a subject and a cerebral cortex of the subject, by applying a treatment voltage between the superior sagittal sinus and the cerebral cortex of the subject.

55. The method according to claim 54, further comprising providing a rest period during which the treatment voltage is not applied, and applying, during the rest period, an opposite voltage between the superior sagittal sinus and the cerebral cortex, the opposite voltage being opposite to the treatment voltage and having a lower magnitude than the treatment voltage.

56. The method according to claim 54, wherein applying the treatment voltage comprises applying a capacitative current.

57. The method according to claim 54, wherein driving the fluid between the superior sagittal sinus and the cerebral cortex of the subject comprises driving the fluid from the cerebral cortex to the superior sagittal sinus of the subject.

58. The method according to any one of claims 54-57, further comprising detecting a pressure difference between the superior sagittal sinus of the subject and the cerebral cortex of the subject, and wherein applying the treatment voltage comprises applying the treatment voltage in response to the detected pressure difference.

59. The method according to claim 58, wherein detecting the pressure difference comprises detecting a voltage between the superior sagittal sinus of the subject and the cerebral cortex of the subject, and wherein applying the treatment voltage comprises applying the treatment voltage in response to the detected voltage.

60. The method according to claim 59, wherein detecting the detected voltage comprises detecting a streaming potential.

61. The method according to claim 59, further comprising implanting a first electrode at the superior sagittal sinus of the subject, and a second electrode at the cerebral cortex of the subject, and wherein detecting the voltage between the superior sagittal sinus of the subject and the cerebral cortex of the subject comprises detecting a voltage between the first and second electrodes.

62. A method, comprising: electroosmotically driving fluid between a renal artery of a subject and a ureter of the subject, by applying a treatment voltage between the renal artery and the ureter of the subject.

63. The method according to claim 62, further comprising providing a rest period during which the treatment voltage is not applied, and applying, during the rest period, an opposite voltage between the renal artery and the ureter, the opposite voltage being opposite to the treatment voltage and having a lower magnitude than the treatment voltage.

64. The method according to claim 62, wherein applying the treatment voltage comprises applying a capacitative current.

65. The method according to claim 62, wherein driving the fluid between the renal artery and the ureter of the subject comprises driving the fluid from the renal artery to the ureter of the subject.

66. The method according to any one of claims 62-65, further comprising detecting a pressure difference between the renal artery of the subject and the ureter of the subject, and wherein applying the treatment voltage comprises applying the treatment voltage in response to the detected pressure difference.

67. The method according to claim 66, wherein detecting the pressure difference comprises detecting a voltage between the renal artery of the subject and the ureter of the subject, and wherein applying the treatment voltage comprises applying the treatment voltage in response to the detected voltage.

68. The method according to claim 67, wherein detecting the detected voltage comprises detecting a streaming potential.

69. The method according to claim 67, further comprising implanting a first electrode at the renal artery of the subject, and a second electrode at the ureter of the subject, and wherein detecting the voltage between the renal artery of the subject and the ureter of the subject comprises detecting a voltage between the first and second electrodes.

70. A method, comprising: electroosmotically driving fluid between an artery entering a lymph node of a subject and a medullary sinus of the lymph node of the subject, by applying a treatment voltage between the artery and the medullary sinus of the subject.

71. The method according to claim 70, further comprising providing a rest period during which the treatment voltage is not applied, and applying, during the rest period, an opposite voltage between the artery and the medullary sinus, the opposite voltage being opposite to the treatment voltage and having a lower magnitude than the treatment voltage.

72. The method according to claim 70, wherein applying the treatment voltage comprises applying a capacitative current.

73. The method according to claim 70, wherein driving the fluid between the artery entering the lymph node and the medullary sinus of the subject comprises driving the fluid from the medullary sinus to the artery entering the lymph node of the subject.

74. The method according to any one of claims 70-73, further comprising detecting a pressure difference between the artery of the subject and the medullary sinus of the subject, and wherein applying the treatment voltage comprises applying the treatment voltage in response to the detected pressure difference.

75. The method according to claim 74, wherein detecting the pressure difference comprises detecting a voltage between the artery of the subject and the medullary sinus of the subject, and wherein applying the treatment voltage comprises applying the treatment voltage in response to the detected voltage.

76. The method according to claim 75, wherein detecting the detected voltage comprises detecting a streaming potential.

77. The method according to claim 75, further comprising implanting a first electrode at the artery of the subject, and a second electrode at the medullary sinus of the subject, and wherein detecting the voltage between the artery of the subject and the medullary sinus of the subject comprises detecting a voltage between the first and second electrodes.

78. A method, comprising: electroosmotically driving fluid between a vitreous cavity of an eye of a subject and a Schlemm's canal of the eye of the subject, by applying a treatment voltage between the vitreous cavity and the Schlemm's canal of the subject.

79. The method according to claim 78, further comprising providing a rest period during which the treatment voltage is not applied, and applying, during the rest period, an opposite voltage between the vitreous cavity and the Schlemm's canal, the opposite voltage being opposite to the treatment voltage and having a lower magnitude than the treatment voltage.

80. The method according to claim 78, wherein applying the treatment voltage comprises applying a capacitative current.

81. The method according to claim 78, wherein driving the fluid between the vitreous cavity and the Schlemm's canal of the subject comprises driving the fluid from the vitreous cavity to the Schlemm's canal of the subject.

82. The method according to any one of claims 78-81, further comprising detecting a pressure difference between the vitreous cavity of the subject and the Schlemm's canal of the subject, and wherein applying the treatment voltage comprises applying the treatment voltage in response to the detected pressure difference.

83. The method according to claim 82, wherein detecting the pressure difference comprises detecting a voltage between the vitreous cavity of the subject and the Schlemm's canal of the subject, and wherein applying the treatment voltage comprises applying the treatment voltage in response to the detected voltage.

84. The method according to claim 83, wherein detecting the detected voltage comprises detecting a streaming potential.

85. The method according to claim 83, further comprising implanting a first electrode at the vitreous cavity of the subject, and a second electrode at the Schlemm's canal of the subject, and wherein detecting the voltage between the vitreous cavity of the subject and the Schlemm's canal of the subject comprises detecting a voltage between the first and second electrodes.

86. A method, comprising: electroosmotically driving fluid between a site within a subarachnoid cavity of a subject and a site outside of the subarachnoid cavity of the subject, by applying a treatment voltage between the site within the subarachnoid cavity and the site outside of the subarachnoid cavity of the subject.

87. The method according to claim 86, further comprising providing a rest period during which the treatment voltage is not applied, and applying, during the rest period, an opposite voltage between the site within the subarachnoid cavity and the site outside of the subarachnoid cavity, the opposite voltage being opposite to the treatment voltage and having a lower magnitude than the treatment voltage.

88. The method according to claim 86, wherein electroosmotically driving the fluid by applying the treatment voltage comprises electroosmotically driving fluid between a site within a subarachnoid cavity of a subject that is asymptomatic of Alzheimer's disease and a site outside of the subarachnoid cavity of the subject, by applying a treatment voltage between the site within the subarachnoid cavity and the site outside of the subarachnoid cavity of the subject that is asymptomatic of Alzheimer's disease.

89. The method according to claim 86, wherein applying the treatment voltage comprises applying a capacitative current.

90. The method according to claim 86, wherein driving the fluid between the site within the subarachnoid cavity and the site outside of the subarachnoid cavity of the subject comprises driving the fluid from the site within the subarachnoid cavity to the site outside of the subarachnoid cavity of the subject.

91. The method according to any one of claims 86-90, further comprising detecting a pressure difference between the site within the subarachnoid cavity of the subject and the site outsider of the subarachnoid cavity of the subject, and wherein applying the treatment voltage comprises applying the treatment voltage in response to the detected pressure difference.

92. The method according to claim 91, wherein detecting the pressure difference comprises detecting a voltage between the site within the subarachnoid cavity of the subject and the site outside of the subarachnoid cavity of the subject, and wherein applying the treatment voltage comprises applying the treatment voltage in response to the detected voltage.

93. The method according to claim 92, wherein detecting the detected voltage comprises detecting a streaming potential.

94. The method according to claim 92, further comprising implanting a first electrode at the site within the subarachnoid cavity of the subject, and a second electrode at the site outside of the subarachnoid cavity of the subject, and wherein detecting the voltage between the site within the subarachnoid cavity of the subject and the site outside of the subarachnoid cavity of the subject comprises detecting a voltage between the first and second electrodes.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0141] FIG. 1 is a schematic illustration of a system for altering throughput of fluid in the brain of a subject, in accordance with some applications of the present invention;

[0142] FIG. 2 is a schematic illustration of a system for altering throughput of fluid in a kidney of a subject, in accordance with some applications of the present invention;

[0143] FIG. 3 is a schematic illustration of a system for altering throughput of fluid in a lymph node of a subject, in accordance with some applications of the present invention;

[0144] FIG. 4 is a schematic illustration of a system for altering throughput of fluid in an eye of a subject, in accordance with some applications of the present invention;

[0145] FIG. 5 is a schematic illustration of a system for sensing of the driving of fluid in an intervertebral disc of a subject, in accordance with some applications of the invention;

[0146] FIG. 6 is a schematic illustration of a system for altering throughput of fluid in the brain of a subject, in accordance with some applications of the invention; and

[0147] FIG. 7 is a schematic illustration of a system for applying a capacitance-based current, in accordance with some applications of the present invention.

DETAILED DESCRIPTION OF EMBODIMENTS

[0148] Reference is made to FIG. 1, which is a schematic illustration of medical apparatus 10, comprising a first electrode 12, a second electrode 14 and a control unit 16, for altering throughput of fluid in the brain of a subject, in accordance with some applications of the invention. According to one application of the present invention, medical apparatus 10 is coupled to a brain 20 of the subject. Typically, first electrode 12 is implanted at a superior sagittal sinus 22 of the subject. Typically, second electrode 14 is implanted at a cerebral cortex 24 of the subject. According to one application of the present invention, control unit 16 is configured to apply a treatment voltage between first electrode 12 and second electrode 14, and to configure the treatment voltage to electroosmotically drive fluid from cerebral cortex 24 to superior sagittal sinus 22. It is hypothesized that this driving of the fluid reduces intracranial pressure (e.g., pressure in the brain), and thereby may be used to treat a subject suffering from elevated intracranial pressure, such as a subject suffering from hydrocephalus or brain trauma. It is also hypothesized that, for some applications, this driving of the fluid may be used to treat a subject suffering from normal pressure hydrocephalus.

[0149] Typically, control unit 16 applies the treatment voltage as a direct current (DC). For some applications of the invention, the control unit is configured to apply the treatment voltage according to a pre-selected schedule, such as a duty cycle, such as for a few hours per day, such as when the subject is sleeping. For example, the control unit may be configured to be controlled and/or powered by an extracorporeal controller, such as a controller comprising a wireless transmitter, disposed in and/or in the vicinity of the subject's bed. For some applications, one or more rest periods during which the treatment voltage is not applied, are provided in the pre-selected schedule. It is hypothesized that for some applications, the rest period facilitates equilibration of charge in the body of the subject. For some such applications, during rest periods in which the treatment voltage is not being applied, an opposite voltage (i.e., a voltage having an opposite sign to the treatment voltage) having a different (e.g., lower) magnitude is applied.

[0150] For some applications of the invention, apparatus 10 is configured to detect a pressure at at least one of the electrodes (e.g., the pressure above atmospheric pressure, at the implantation site of the electrode), and to apply the treatment voltage in response to the detected pressure. For example, apparatus 10 may be configured to detect pressure at cerebral cortex 24, and to apply the treatment voltage if the detected pressure is greater than a threshold pressure.

[0151] For some applications of the present invention, apparatus 10 comprises a pressure sensor 18, configured to detect the pressure. For some applications of the invention, pressure sensor 18 comprises a mechanical transducer-based pressure sensor, as is known in the art. That is, for some applications, the pressure sensor is configured to detect the pressure by detecting the mechanical pressure pressing on a component of the pressure sensor. For some such applications, and as shown in FIG. 1, pressure sensor 18 is coupled to and/or integrated with at least one of the electrodes, such as electrode 12.

[0152] For some applications, apparatus 10 is configured to sense a pressure difference between the implantation sites of first electrode 12 and second electrode 14, and to apply the treatment voltage in response to the detected pressure difference. For example, and as shown in FIG. 1, apparatus 10 may comprise two or more pressure sensors 18, each pressure sensor being coupled to and/or integrated with a respective electrode, and control unit 16 being configured to sense the difference between the pressure detected by each pressure sensor.

[0153] Alternatively or additionally, apparatus 10 may sense the pressure difference by detecting a voltage, such as a streaming potential, between the electrodes, that is indicative of the pressure difference between the sites. For example, control unit 16 may comprise voltage-detecting circuitry 17, configured to detect the voltage between electrodes 12 and 14, and may be configured to apply the treatment voltage only if the detected voltage is greater than a threshold voltage. Typically, control unit 16 is configured to apply the voltage only when the detected voltage between first electrode 12 and second electrode 14 is greater than 2 mV (e.g., greater than 20 mV, but typically less than 500 mV, for example, less than 50 mV). For some such applications, apparatus 10 may be considered to comprise a pressure detector that comprises electrodes 12 and 14, and circuitry 17.

[0154] Typically, the detected voltage is detected while the treatment voltage is not applied. For example, control unit 16 may be configured to apply the treatment voltage and detect the detected voltage in a sequence, and/or to periodically stop applying the treatment voltage so as to detect the detected voltage.

[0155] For some applications of the invention, control unit 16 comprises a receiver 19 (e.g., an antenna), which receives power wirelessly from an extracorporeal device, e.g., a mattress-based transmitter, or a transmitter coupled to a belt, hat, eyeglasses, or clothing item of the subject. For some applications, receiver 19 of control unit 16 receives power wirelessly from an implanted transmitter coupled to a power source (e.g., a battery). Alternatively or additionally, the control unit receives power from a power source (e.g., a battery), which may be in a common housing with the control unit.

[0156] Reference is now made to FIG. 2, which is a schematic illustration of medical apparatus 10, comprising generally the same components as shown in FIG. 1, being used to alter throughput of fluid in a kidney of a subject, in accordance with some applications of the invention. According to one application of the present invention, medical apparatus 10 is coupled to a kidney 30 of the subject. Typically, first electrode 12 is coupled to a renal artery 32 of the subject, and second electrode 14 is coupled to a ureter 34 of the subject. According to one application of the present invention, control unit 16 is configured to apply a voltage between first electrode 12 and second electrode 14, and to configure the voltage to electroosmotically drive fluid from renal artery 32 to ureter 34. It is hypothesized that this driving of the fluid is beneficial for subjects suffering from kidney disease and/or congestive heart failure (CHF).

[0157] As described with reference to FIG. 1, for some applications, apparatus 10 is configured to detect a pressure at at least one of the electrodes (e.g., the pressure above atmospheric pressure, at the implantation site of the electrode), and to apply the treatment voltage in response to the detected pressure. As also described with reference to FIG. 1, for some applications, apparatus 10 is configured to detect a pressure difference between the implantation sites of the electrodes, and to apply the treatment voltage in response to the detected pressure difference. As further described with reference to FIG. 1, for some such applications, apparatus 10 is configured to detect the pressure difference by detecting a voltage, such as a streaming potential, between the electrodes, that is indicative of the pressure difference between the sites. When apparatus 10 is implanted as shown in FIG. 2, the apparatus may thereby be configured to detect the pressure at renal artery 32 (e.g., the pressure above atmospheric pressure), and/or to detect the pressure difference and/or the voltage between the renal artery and ureter 34, and to apply the treatment voltage if the detected pressure, pressure difference, and/or voltage is greater than a threshold pressure, pressure difference, and/or voltage.

[0158] Typically, the detected voltage is detected while the treatment voltage is not applied. For example, control unit 16 may be configured to apply the treatment voltage and detect the detected voltage in a sequence, and/or to periodically stop applying the treatment voltage so as to detect the detected voltage.

[0159] Reference is now made to FIG. 3, which is a schematic illustration of medical apparatus 10 for altering throughput of fluid in a lymph node of a subject, comprising generally the same components as shown in FIG. 1, in accordance with some applications of the invention. According to one application of the present invention, medical apparatus 10 is coupled to a lymph node 40 of the subject. Typically, first electrode 12 is coupled to a blood vessel, such as an artery 42 (or similarly a vein), in proximity to (e.g., entering) lymph node 40 of the subject, and second electrode 14 is coupled to a medullary sinus 44 of the lymph node (or at another site within the lymph node). According to one application of the present invention, control unit 16 is configured to apply a voltage between first electrode 12 and second electrode 14, and to configure the voltage to electroosmotically drive fluid from medullary sinus 44 toward (e.g., into) artery 42.

[0160] As described with reference to FIG. 1, for some applications, apparatus 10 is configured to detect a pressure at at least one of the electrodes (e.g., the pressure above atmospheric pressure, at the implantation site of the electrode), and to apply the treatment voltage in response to the detected pressure. As also described with reference to FIG. 1, for some applications, apparatus 10 is configured to detect a pressure difference between the implantation sites of the electrodes, and to apply the treatment voltage in response to the detected pressure difference. As further described with reference to FIG. 1, for some such applications, apparatus 10 is configured to detect the pressure difference by detecting a voltage, such as a streaming potential, between the electrodes, that is indicative of the pressure difference between the sites. When apparatus 10 is implanted as shown in FIG. 3, the apparatus may thereby be configured to detect the pressure at medullary sinus 44 (e.g., the pressure above atmospheric pressure), and/or to detect the pressure difference and/or the voltage between the medullary sinus and artery 42, and to apply the treatment voltage if the detected pressure, pressure difference, and/or voltage is greater than a threshold pressure, pressure difference, and/or voltage.

[0161] Typically, the detected voltage is detected while the treatment voltage is not applied. For example, control unit may be configured to apply the treatment voltage and detect the detected voltage in a sequence, and/or to periodically stop applying the treatment voltage so as to detect the detected voltage.

[0162] Reference is now made to FIG. 4, which is a schematic illustration of medical apparatus 10, comprising generally the same components as shown in FIG. 1, for altering throughput of fluid in an eye of a subject, in accordance with some applications of the invention. According to one application of the present invention, medical apparatus 10 is coupled to an eye 50 of the subject. Typically, first electrode 12 is coupled to a vitreous cavity 52, and second electrode 14 is coupled to Schlemm's canal 54 of the subject. According to one application of the present invention, control unit 16 is configured to apply a voltage between first electrode 12 and second electrode 14, and to configure the voltage to electroosmotically drive fluid from vitreous cavity 52 to Schlemm's canal 54 in order to reduce intraocular pressure.

[0163] As described with reference to FIG. 1, for some applications, apparatus 10 is configured to detect a pressure at at least one of the electrodes (e.g., the pressure above atmospheric pressure, at the implantation site of the electrode), and to apply the treatment voltage in response to the detected pressure. As also described with reference to FIG. 1, for some applications, apparatus 10 is configured to detect a pressure difference between the implantation sites of the electrodes, and to apply the treatment voltage in response to the detected pressure difference. As further described with reference to FIG. 1, for some such applications, apparatus 10 is configured to detect the pressure difference by detecting a voltage, such as a streaming potential, between the electrodes, that is indicative of the pressure difference between the sites. When apparatus 10 is implanted as shown in FIG. 4, the apparatus may thereby be configured to detect the pressure at vitreous cavity 52 (e.g., the pressure above atmospheric pressure), and/or to detect the pressure difference and/or the voltage between the vitreous cavity and Schlemm's canal 54, and to apply the treatment voltage if the detected pressure, pressure difference, and/or voltage is greater than a threshold pressure, pressure difference, and/or voltage.

[0164] Typically, the detected voltage is detected while the treatment voltage is not applied. For example, control unit 16 may be configured to apply the treatment voltage and detect the detected voltage in a sequence, and/or to periodically stop applying the treatment voltage so as to detect the detected voltage.

[0165] Reference is made to FIG. 5 which is a schematic illustration of medical apparatus 10, comprising generally the same components as shown in FIG. 1, for driving fluid in an intervertebral disc 60 of a subject, in accordance with some applications of the invention. According to one application of the present invention, medical apparatus 10 is coupled to disc 60 of the subject. Typically, first electrode 12 is implanted in a nucleus pulposus 62 of the disc, and second electrode 14 is implanted at a site outside of the nucleus pulposus, such as coupled to an outer surface of an annulus fibrosus 64 of the disc. For some applications, electrode 12 comprises a rigid support element having a non-conductive outer surface. The support element aids in the insertion of the electrode through annulus fibrosus 64 into nucleus pulposus 62, and in holding the electrode in place upon insertion.

[0166] According to one application of the present invention, control unit 16 is configured to apply a voltage between first electrode 12 and second electrode 14, and to configure the voltage to electroosmotically drive fluid from the site outside nucleus pulposus 62, into the nucleus pulposus. It is hypothesized that this driving of the fluid is beneficial for subjects suffering from intervertebral disc fluid loss, by generally treating and/or preventing further degeneration in disc 60. Alternatively or additionally, control unit 16 may be configured to configure the voltage to electroosmotically drive fluid from the nucleus pulposus, to the site outside the nucleus pulposus.

[0167] As described with reference to FIG. 1, for some applications, apparatus 10 is configured to detect a pressure at at least one of the electrodes (e.g., the pressure above atmospheric pressure, at the implantation site of the electrode), and to apply the treatment voltage in response to the detected pressure. As also described with reference to FIG. 1, for some applications, apparatus 10 is configured to detect a pressure difference between the implantation sites of the electrodes, and to apply the treatment voltage in response to the detected pressure difference. As further described with reference to FIG. 1, for some such applications, apparatus 10 is configured to detect the pressure difference by detecting a voltage, such as a streaming potential, between the electrodes, that is indicative of the pressure difference between the sites. When apparatus 10 is implanted as shown in FIG. 5, and is configured to drive fluid into the nucleus pulposus, the apparatus may thereby be configured to detect the pressure at nucleus pulposus 62 (e.g., the pressure above atmospheric pressure), and/or to detect the pressure difference and/or the voltage between the nucleus pulposus and the site outside of the nucleus pulposus, and to apply the treatment voltage if the detected pressure, pressure difference, and/or voltage is smaller than a threshold pressure, pressure difference, and/or voltage.

[0168] As described hereinabove, apparatus 10 may alternatively or additionally be configured to drive fluid out of the nucleus pulposus. For such applications, the apparatus may thereby be configured to detect the pressure at the nucleus pulposus (e.g., the pressure above atmospheric pressure), and/or to detect the pressure difference and/or the voltage between the nucleus pulposus and the site outside of the nucleus pulposus, and to apply the treatment voltage if the detected pressure, pressure difference, and/or voltage is greater than a threshold pressure, pressure difference, and/or voltage.

[0169] Typically, the detected voltage is detected while the treatment voltage is not applied. For example, control unit may be configured to apply the treatment voltage and detect the detected voltage in a sequence, and/or to periodically stop applying the treatment voltage so as to detect the detected voltage.

[0170] Reference is made to FIG. 6 which is a schematic illustration of medical apparatus 10, comprising generally the same components as shown in FIG. 1, for driving fluid in brain 20 of a subject, in accordance with some applications of the invention. Typically, first electrode 12 is implanted in a subarachnoid cavity 80 of the brain of the subject, and second electrode 14 is implanted at a site outside of the subarachnoid cavity, such as outside of the brain of the subject. For example, and as shown in FIG. 6, second electrode 14 may be integral with control unit 16 (e.g., integral with a casing thereof), and control unit 16 may be subcutaneously implanted elsewhere in the body, such as at a site in the torso of the subject. For some applications, first electrode 12 is placed at a different site in the brain of the subject.

[0171] According to one application of the present invention, control unit 16 is configured to apply a voltage between first electrode 12 and second electrode 14, and to configure the voltage to electroosmotically drive fluid out of subarachnoid cavity 80. It is further hypothesized by the inventor that the driving of the fluid is beneficial for subjects suffering from and/or at risk of Alzheimer's disease (e.g., that are asymptomatic of Alzheimer's disease), by facilitation of clearance of substances, such as amyloid-beta and metal ions (e.g., iron and copper ions), from the brain of the subject. For example, reduction of the concentration of amyloid beta monomers and/or oligomers from the brain may (1) inhibit the formation and/or growth of amyloid-beta plaques in the brain, and/or (2) reduce direct toxic effects of the oligomers on neurons of the brain. It is also hypothesized that, for some applications, this driving of the fluid may be used to treat a subject suffering from normal pressure hydrocephalus.

[0172] It is further hypothesized by the inventor that the driving of the fluid reduces the volume of fluid in at least parts of the brain, such as within ventricles of the brain, suppressing enlargement of the ventricles, e.g., caused by fluid pressure in the ventricles.

[0173] As described with reference to FIG. 1, for some applications, apparatus 10 is configured to detect a pressure at at least one of the electrodes (e.g., the pressure above atmospheric pressure, at the implantation site of the electrode), and to apply the treatment voltage in response to the detected pressure. As also described with reference to FIG. 1, for some applications, apparatus 10 is configured to detect a pressure difference between the implantation sites of the electrodes, and to apply the treatment voltage in response to the detected pressure difference. As further described with reference to FIG. 1, for some such applications, apparatus 10 is configured to detect the pressure difference by detecting a voltage, such as a streaming potential, between the electrodes, that is indicative of the pressure difference between the sites. When apparatus 10 is implanted as shown in FIG. 6, the apparatus may thereby be configured to detect the pressure at subarachnoid cavity 80 (e.g., the pressure above atmospheric pressure), and/or to detect the pressure difference and/or the voltage between the subarachnoid cavity and the site outside of the subarachnoid cavity, and to apply the treatment voltage if the detected pressure, pressure difference, and/or voltage is greater than a threshold pressure, pressure difference, and/or voltage.

[0174] Typically, the detected voltage is detected while the treatment voltage is not applied. For example, control unit may be configured to apply the treatment voltage and detect the detected voltage in a sequence, and/or to periodically stop applying the treatment voltage so as to detect the detected voltage.

[0175] Reference is now made to FIG. 7, which is a schematic illustration of medical apparatus 100, for applying a capacitance-based current to a subject, in accordance with some applications of the invention. Typically, apparatus 100 comprises apparatus 10 and/or components thereof but, in apparatus 100, first electrode 12 and second electrode 14 are insulated with an insulating material 102 (e.g., silicone). Typically, when control unit 16 applies a voltage between first electrode 12 and second electrode 14, a capacitance-based current flows from first electrode 12 to second electrode 14, resulting in fluid electroosmotically moving from a first site 72 in the body toward a second site in the body. For example, this technique may be practiced to electroosmotically drive fluid (e.g., to alter the throughput of fluid) between any of the sites described in FIGS. 1-6, mutatis mutandis. For some applications, insulating material 102 inhibits corrosion of electrodes 12 and/or 14. For some applications, only one of electrodes 12 and 14 is insulated with insulating material 102.

[0176] Reference is again made to FIGS. 1-7. For some applications (e.g., as described with reference to FIG. 5, mutatis mutandis), it may be desirable to increase the pressure difference between the implantation sites of electrodes 12 and 14. For some such applications, the apparatus is thereby configured to detect the pressure (e.g., the pressure above atmospheric pressure), and/or to detect the pressure difference and/or the voltage between the implantation sites, and to apply the treatment voltage if the detected pressure, pressure difference, and/or voltage is smaller than a threshold pressure, pressure difference, and/or voltage.

[0177] Reference is again made to FIGS. 1-7. For some applications, electrode 12 and/or electrode 14 comprise more than one electrode, respectively, e.g., so as to distribute the treatment voltage over a larger region of a tissue compared to a single electrode. For example, with respect to the configuration shown in FIG. 1, a plurality of electrodes 14 may be implanted in cerebral cortex 24, each of the electrodes 14 being implanted at a different region of the cerebral cortex, so as to drive fluid from each of the regions of the cerebral cortex toward superior sagittal sinus 22. Similarly, for some applications, electrode 12 and/or electrode 14 may comprise a large (e.g., elongate, planar, and/or a mesh) electrode that is thereby configured to distribute the treatment voltage over a larger region of tissue compared to a smaller electrode.

[0178] Reference is again made to FIGS. 1-6. It is to be noted that FIGS. 1-6 show examples of anatomical sites in which apparatus 10 may be used, and that apparatus 10 may be used in anatomical sites (e.g., other anatomical sites) that include a native membrane across which a pressure difference exists.

[0179] It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.